Westmount Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $345K | Buy |
3,110
+10
| +0.3% | +$1.11K | 0.09% | 168 |
|
|
2025
Q1 | $347K | Sell |
3,100
-213
| -6% | -$23.9K | 0.11% | 161 |
|
|
2024
Q4 | $306K | Buy |
3,313
+243
| +8% | +$22.4K | 0.09% | 170 |
|
|
2024
Q3 | $257K | Buy |
3,070
+5
| +0.2% | +$419 | 0.08% | 184 |
|
|
2024
Q2 | $210K | Buy |
3,065
+6
| +0.2% | +$412 | 0.07% | 200 |
|
|
2024
Q1 | $224K | Sell |
3,059
-137
| -4% | -$10K | 0.08% | 187 |
|
|
2023
Q4 | $259K | Sell |
3,196
-107
| -3% | -$8.67K | 0.11% | 158 |
|
|
2023
Q3 | $248K | Buy |
3,303
+260
| +9% | +$19.5K | 0.11% | 163 |
|
|
2023
Q2 | $235K | Sell |
3,043
-95
| -3% | -$7.32K | 0.1% | 158 |
|
|
2023
Q1 | $260K | Sell |
3,138
-117
| -4% | -$9.71K | 0.12% | 149 |
|
|
2022
Q4 | $279K | Buy |
+3,255
| New | +$279K | 0.15% | 140 |
|